Pancreatic Cancer Research

ResearcherDartmouth CollegeNo recent work listed

Michael B. Sporn

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5108192090; NIH RePORTER profile ID 2212583. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
1
Collaborators
2
Papers, trials and grants by year

2012: 1 grant · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper

Papers 2

  1. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.02.021↗
  2. The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer. First author DOI 10.1093/carcin/bgw099↗

Grants 1

  1. New Triterpenoids for Chemoprevention and Therapy of Cancer R01CA078814↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ana S. Leal · 2 shared papers, 2016–2017 · strength 0.17
  2. Karen T. Liby · 2 shared papers, 2016–2017 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.